Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT06054178
PHASE2
Identification of Nerves Using Fluorescein Sodium
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
The purpose of this study is to see if there is benefit in using an IV contrast (sodium fluorescein) to identify nerves during head and neck surgery.
Official title: Intraoperative Nerve Identification With Fluorescein Sodium
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-11-07
Completion Date
2025-09-01
Last Updated
2025-07-28
Healthy Volunteers
No
Conditions
Interventions
DRUG
Fluorescein Sodium
Intravenous administration of 1 mg/kg. If initial dosing is insufficient, additional doses may be administered up to a total of 3 mg/kg
Locations (1)
Stanford Medical Center
Palo Alto, California, United States